In this webcast, Dr. Vinod Thourani, Dr. Howard Herrmann, and Dr. Michael Reardon discuss the latest findings on the expanded indications of transcatheter aortic valve replacement (TAVR) in intermediate risk and high risk patients.

In this webcast experts in the field of cardiology discuss the future of low risk TAVR procedures and new criteria for TAVR use in patients, including STS scores, frailty, and disability for enrollment in a low risk trial.